| Catalog No. |
Size |
Price |
Figures |
Z00060-1 mg
| 1 mg | $ 420.00 | References:
- Natuk RJ, et al. Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge. J. Virol. May 2006; 80(9): 4447-4457.
- Quenelle DC, et al. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. Vaccine. Mar 2006; 24(10): 1515-1522.
|
|---|
| Full Name | | Herpes Simplex Virus (HSV)-2 gD |
|
| Abbreviated Name-1 | Herpes Simplex Virus-2 gD |
|---|
| Abbreviated Name-2 | HSV-2 gD |
| Description | The protein is an E. coli-derived recombinant protein. GenScript Herpes Simplex Virus (HSV)-2 gD contains the immunodominant regions of glycoprotein D. |
| Source | E. coli |
| Purity | The protein is >95% pure as determined by 10% PAGE (Coomassie staining). |
| Storage | The protein is shipped at ambient temperature. Upon arrival, store it at -20°C. |
| Concentration | 1 mg/ml in 25 mM Tris-HCl, 1 mM EDTA, 50% glycerol |
| Stability | The protein will remain stable for five years if stored frozen and for one month in solution if stored at room temperature. |
| Specificity | The protein is immunoreactive with sera of HSV-infected individuals. |
| Applications | The protein can serve as an antigen in ELISA and Western Blots and an excellent antigen in detection of HSV. It shows minimal specificity problems. |